SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Biotech Bay
Nothing Like A Room Full Of Brainiacs To Make A Columnist Feel Small
November 21, 2005
 · 
1 min read
Biotech Beach
The Day In Review: More Good Data For Lucentis From Genentech
November 8, 2005
 · 
1 min read
Drug Development
Cancer Drug Found To Cut Some Relapses By Half
October 20, 2005
 · 
1 min read
The Day In Review: Biotech Falls Despite Genentech
October 19, 2005
 · 
1 min read
The Day In Review: Biotech Strong While Market Slides
October 19, 2005
 · 
1 min read
Genentech Lung-Cancer Drug Stirs Excitement On Wall Street
October 19, 2005
 · 
1 min read
The Day In Review: Biotech Ends Winning Streak
October 19, 2005
 · 
1 min read
Drug Development
The Day In Review: Biotech Gains A Substantial 1+%; A Wealth of Positive News Helps Sector Move Higher
October 19, 2005
 · 
1 min read
Drug Development
Genentech
October 19, 2005
 · 
6 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026
 · 
10 min read
Press Releases
FDA Approves First Single-Dose Generic Treatment for Influenza
June 18, 2026
 · 
2 min read
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
 · 
14 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
June 2, 2026
 · 
7 min read
Press Releases
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 1, 2026
 · 
6 min read
Press Releases
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
May 26, 2026
 · 
5 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
 · 
19 min read
Press Releases
Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer
May 19, 2026
 · 
12 min read
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
 · 
10 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Load More